Natixis Investment Managers International’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-25,456
| Closed | -$2.11M | – | 267 |
|
|
2022
Q2 | $2.11M | Buy |
25,456
+22,924
| +905% | +$1.9M | 0.04% | 124 |
|
|
2022
Q1 | $195K | Buy |
+2,532
| New | +$195K | ﹤0.01% | 434 |
|
|
2018
Q4 | – | Sell |
-4,605
| Closed | -$447K | – | 96 |
|
|
2018
Q3 | $447K | Buy |
4,605
+484
| +12% | +$47K | 0.02% | 495 |
|
|
2018
Q2 | $388K | Buy |
+4,121
| New | +$388K | 0.02% | 472 |
|
|
2015
Q4 | – | Sell |
-3,882
| Closed | -$409K | – | 407 |
|
|
2015
Q3 | $409K | Buy |
3,882
+727
| +23% | +$76.6K | 0.06% | 229 |
|
|
2015
Q2 | $432K | Buy |
+3,155
| New | +$432K | 0.05% | 229 |
|